Global Stem Cells Industry 2014 to 2020 - Industry Applications, Market Size, Segmentation, Company Share

Submitted by: Submitted by

Views: 93

Words: 715

Pages: 3

Category: Business and Industry

Date Submitted: 05/21/2014 11:51 PM

Report This Essay

The global market for stem cells is expected to reach USD 170.15 billion by 2020, according to a new study by Grand View Research, Inc. Growing prevalence of chronic diseases such as cardiovascular and liver disease, diabetes and cancer coupled with the presence of high unmet medical needs in these disease segments is expected to drive market growth during the forecast period. Moreover, increasing government support pertaining to funding R&D initiatives and the growing demand for medical tourism and stem cell banking services is expected to boost the demand for stem cells over the next six years. The future of this market is expected to be driven by opportunities such as the growing global prevalence of neurodegenerative diseases, increasing demand for contract research outsourcing services and the substitution of animal tissues by stem cells in the

The stem cells technology market was valued at USD 12.88 billion in 2013 and is expected to grow at a CAGR of over 12.0% during the forecast period. This market was dominated by the cell acquisitions technology segment in terms of share in 2013 owing to the fact that this technology serves as the foremost step to process involving stem cells culture. The global stem cell acquisition technology market is expected to reach USD 10.88 billion by 2020, growing at a CAGR of over 14.0% over the next six years.

The report “Stem Cells Market Analysis By Product (Adult Stem Cells, Human Embryonic Cells, Pluripotent Stem Cells), By Application (Regenerative Medicine, Drug Discovery and Development) And Segment Forecasts To 2020,” is available now to Grand View Research customers and can also be purchased directly at

http://www.grandviewresearch.com/industry-analysis/stem-cells-market

Further key findings from the study suggest:

• Adult stem cells segment dominated the overall market in 2013 with a share of over 80.0% on account of features such as low contamination probability, better acceptance by the human body and...